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Abstract
Purpose: The purpose of this study was to predict the base curve of the spectacle correction of patients in
order to minimize their aniseikonia. We hypothesized that in order to correct the patient’s aniseikonia, we can
manipulate the base curve of the subject’s prescription to change the magnification, without ultimately
altering the prescription.
Methods: Ten female adults with spherical equivalent of ≥ 1 D anisometropia, and visual acuity of 20/25 or
greater corrected vision, were studied. The participants were evaluated for anisometropia while wearing their
habitual spectacles (i.e. non-size lens) and reassessed 4 weeks later (± 2 weeks). A-scan ultrasound biometry
and keratometry measurement were determined at first visit. Ocular history, visual acuity, refraction,
stereopsis at near, and aniseikonia subjective symptoms was evaluated at each visit. Aniseikonia amount was
measured by the Brecher test and Aniseikonia Inspector Software test for both spectacles and with contact
lenses. Size lens spectacles were prescribed according to the findings of the first visit with new frames using
two base curves: 2 D (the flattest base curve) and 6 D (steepest base curve) for the subjects to be used full
time.
Results: Seven subjects were classified as axial anisometropes and three had the mixed type. Anisometropia
spherical equivalent of ≥ 1 D caused aniseikonia of at least 1 %. A good model of predication about the
relationship between the axial length and anisometropic SE difference between the two eyes was shown.
Visual acuity improved ((P < 0.05) one line with size lens spectacles. Stereopsis was not affected (P > 0.05)
for all subjects except one, who showed improvement. Aniesikonia decreased with size lens spectacles by 57.5
% from the first visit (P < 0.05). Aniseikonia improved more when the subjective phoria was compensated by
loose prism, as needed, to 95 percent (P < 0.05), regardless of the subject’s anisometropia type. There were no
statistically significant (P > 0.05), differences of the symptoms between habitual spectacles, contact lenses and
size lens spectacles, but there was a clinically significant change of headache, asthenopia, photophobia and
reading difficulity with size lens spectacles compared to habitual spectacles and contact lenses. The mean
average of the two aniseikonia tests was 0.7845 percent per one diopter of anisometropia spherical equivalent.
Conclusions: Manipulation of the size lens spectacle base curve helps to correct aniseikonia. Prism is one of the
option to treat aniseikonia but further study is necessary to show the relation between aniseikonia and prism.
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!
ABSTRACT!
 
Purpose: The purpose of this study was to predict the base curve of the spectacle correction of 
patients in order to minimize their aniseikonia. We hypothesized that in order to correct the 
patient’s aniseikonia, we can manipulate the base curve of the subject’s prescription to change 
the magnification, without ultimately altering the prescription.  
Methods: Ten female adults with spherical equivalent of ≥ 1 D anisometropia, and visual acuity 
of 20/25 or greater corrected vision, were studied. The participants were evaluated for 
anisometropia while wearing their habitual spectacles (i.e. non-size lens) and reassessed 4 weeks 
later (± 2 weeks).  A-scan ultrasound biometry and keratometry measurement were determined at 
first visit. Ocular history, visual acuity, refraction, stereopsis at near, and aniseikonia subjective 
symptoms was evaluated at each visit. Aniseikonia amount was measured by the Brecher test and 
Aniseikonia Inspector Software test for both spectacles and with contact lenses.  Size lens 
spectacles were prescribed according to the findings of the first visit with new frames using two 
base curves: 2 D (the flattest base curve) and 6 D (steepest base curve) for the subjects to be used 
full time. 
Results: Seven subjects were classified as axial anisometropes and three had the mixed type. 
Anisometropia spherical equivalent of ≥ 1 D caused aniseikonia of at least 1 %. A good model of 
predication about the relationship between the axial length and anisometropic SE difference 
between the two eyes was shown. Visual acuity improved ((P < 0.05) one line with size lens 
spectacles. Stereopsis was not affected (P > 0.05) for all subjects except one, who showed 
improvement. Aniesikonia decreased with size lens spectacles by 57.5 % from the first visit (P < 
0.05).  Aniseikonia improved more when the subjective phoria was compensated by loose prism, 
as needed, to 95 percent (P < 0.05), regardless of the subject’s anisometropia type. There were no 
statistically significant (P > 0.05), differences of the symptoms between habitual spectacles, 
contact lenses and size lens spectacles, but there was a clinically significant change of headache, 
asthenopia, photophobia and reading difficulity with size lens spectacles compared to habitual 
spectacles and contact lenses. The mean average of the two aniseikonia tests was 0.7845 percent 
per one diopter of anisometropia spherical equivalent. 
Conclusions: Manipulation of the size lens spectacle base curve helps to correct aniseikonia. 
Prism is one of the option to treat aniseikonia but further study is necessary to show the relation 
between aniseikonia and prism. 
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INTRODUCTION!
  
Anisometropia is a visual condition in which a patient’s left and right prescriptions are 
unequal.1,2,3 Despite this straightforward definition for this uncommon condition, there is still a 
lack of agreement about its origin.  There are some misunderstandings about the degree to which 
patients’ eyes need be anisometropic to qualify for clinical significance.  According to 
Woodhouse, a difference in refractive error of more than 1.00 diopter in spherical equivalent is 
considered significant.4 Some studies provide a more detailed definition for anisometropia.  
Oaastadimoghaddam et al. defines anisometropia as the interocular difference in spherical 
equivalent refractive error on the non-cycloplegic refraction.5 The implications of 
Oaastadimoghaddam’s et al. definition works to provide a classification scheme for 
anisometropia.5 This is important because there are different ways in which a patient’s eyes can 
have unequal refractive power. 
For instance, anisoastigmatism is a condition where a difference (≥ 1.00 D) in interocular 
cylinder refraction exists. There are further classifications for anisometropic eyes that are both 
myopic and hyperopic. If a difference in spherical equivalent difference is 1.00 D or more, and 
both eyes are myopic, the patient has anisomyopia; whereas, a spherical equivalent difference is 
1.00 D with two hyperopic eyes the patient has anisohyperopia. It is important to discuss the 
condition of anisometropia and the nuances of the separate, yet similar conditions of 
anisomyopia, anisohyperopia, anisoastigmatism in order to understand their relationship with 
other conditions such as amblyopia and strabismus.5 
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Anisometropia and Visual Development 
 
Anisometropia is considered to be one of the leading causes of amblyopia.6 Though the 
connection between anisometropia and amblyopia is understandable, the mechanism of 
anisometropic amblyopia is poorly understaood. Von Noorden claims that one explanation might 
be there is active suppression of the fovea of the defocused eye to eliminate sensory interference 
caused by the conflicting superimposition of a focused and defocused image.  In order to get a 
better understanding of these conditions independently, it is worthwhile to review a few studies 
on the presence of anisometropia in children.7 
  One study put forth by Birch et al. found that 25% of the children with anisometropia at 
age 1.5 years were still anisometropic at age four.  This study suggests that the individuals have 
the ability to decrease the differences in refractive power between their eyes, especially when 
anisometropia is detected at a young age .8 Another study from Robert and Adams supports this 
observation.9 Robert and Adams claims that anisometropia in infants is often transitory, and 
holds little risk of causing amblyopia after maturity.  That said, infants with high anisometropia 
(≥ 3D) at age 1 are likely to remain anisometropic at age 4 and have a significant risk of 
becoming amblyopic in maturity.  In the severity of amblyopia and the difference in refraction 
display a correlation with both myopes and hypermetropes; that said, there is one study the 
shows a greater correlation between anisometropia and refraction in myopes.5 It is being 
expected that a child with 1D or more of anisohyperopia would be more likely to become 
amblyopic than a child with an equivalent difference in two myopic eyes.5  This expectation 
supports the assertion made by Von Noorden that the mechanism of anisometropic amblyopia is 
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actively inhibiting the fovea in order to reduce sensory interference of the superimposition of one 
focused and one unfocused image.9  
According to Borchert et al., the amount of anisometropia varies in different studies; 
anisometropia may be dependent on age inclusion criteria, history of ocular pathology, and 
etiology of various ocular conditions.10 There is little evidence to show that ethnic or racial 
difference play a role in the development of anisometropia, because these factors have not been 
studied directly, nor have environmental factors been shown to play a role in the development of 
anisometropia.10  
 
Anisometropia and Emmetropization 
 
Though it is possible for anisometropia to lessen as a child matures, Sjostrand reports that 
high anisometropia (≥ 3.00 D) at 1 year of age will likely persist into maturity in his study.6 A 
study in 2006 by Eva Larson and Gred Holmstrom found similar results.  In their study Larson 
and Holmstrom found that children with high anisometropia (≥ 2.00 D) remained anisometropic 
during their study.  They confirmed through multiple regression analysis that anisometropia of 
2.00 D or more at 2.5 years old was the only risk factor for anisometropia of 1.00 D or more at 
10 years old.11 Larson and Holmstrom also discovered that children with cryotreated severe ROP 
had the high occurrence of anisometropia or high anisometropia (≥ 2.00 D) in all of their three 
retinoscopic examination results.  From this observation of children maturing with anisometropia 
(i.e. the prevalence of anisometropia persisted), Larson and Holmstrom concluded that it was 
likely that the process of emmetropization had already been disturbed in the early stages of life.11 
The impact that anisometropia has on emmetropization is difficult to measure, but the 
effect is understandable.  According to an article from Barrett et al., the prevalence of 
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anisometropia is greater in groups that are highly ametropic, and this suggests that 
emmetropization failures underlying anisometropia and ametropia might be related.12 The 
connection between the amount of ametropia and the prevalence and degree of anisometropia 
implies that an increase in the failure of emmetropization is linked with an increasing failure of 
coordinated eye growth across both eyes.12  It is likely then, understanding the origins of 
anisometropia could provide greater insight into our understanding of the origins of ametropia. 
In addition to research that shows the prevalence of anisometropia in children through 
adolescence, there are studies that show there is stable prevalence of anisometropia between the 
ages of 20 and 40 years: around 11-13% of subjects, in a large scale study carried out by Qin et 
al, exhibited anisometropia of ≥ 1.00D in spherical equivalent.13  Another sample from 1997 of 
approximately 4500 US adults 40 and older found that anisometropia (i.e. ≥ 1.00D difference in 
spherical equivalent refraction) increased with age in the population from about approximately 
4.8% when subjects were 40-49 years old, to about 14.8% when subjects were aged 80 years and 
older.  This increase of anisometropia in aging individuals is evident in many cross-sectional, 
population based studies cited in “The relationship between anisometropia and amblyopia.”12 
So according to many researchers the prevalence of anisometropia can be developed 
throughout youth, and manifest in severe forms in later ages; however, there are other studies 
that show that some cases of anisometropia are linked to congenital and other etiologic 
mechanisms of anisometropia.14 Tomac claims that the etiology of anisometropia differs at 
different ages.  Tomac goes to argue that main causes of anisometropia in childhood are 
congenital, such as cataracts, or asymmetry of the biometric components of the eye, like the axial 
length.  For older patients with anisometropia, it is more likely that the condition was acquired.  
Trauma, glaucoma, and cataract, as well as some surgeries have the potential to create 
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anisometropia in older individuals.14 Most reports on the prevalence of anisometropia shows a 
wide range. For instance, in Myanmar the prevalence of anisometropia is 35.5%, versus 1.6% in 
Australia.5,15 This does not help to clear up the cultural or ethnical implications of anisometropia, 
but offers an insight into the impact it has on different groups of people nonetheless. 
Researchers, however, say it remains unclear how geographic differences affects myopia. 
Morgan thinks sunlight may stimulate the release of dopamine from the retina and inhibit the 
elongation of the eye that results in myopia.47 The mechanics of how sunlight protects their eyes 
are not clearly understood. Another theory speculates that blue light from the sun protects from 
the condition.47 Researchers say kids and teens need to get enough sunlight during the critical 
years of their development while their eyeballs are still growing.47 There is also the possibility 
that larger numbers of unilateral pseudophakes or aphakes in equatorial countries skew these 
demographics. The epidemiology of anisometropia has been discussed in many reports, but 
reports are limited that investigate the wide age ranges of the prevalence of anisometropia. 
Though it is important to realize that the prevalence of anisometropia among aging 
individuals is increasing, it is more important to emphasize the prevalence of anisometropia in 
youths because of the association that it has with amblyopia as well as the potential 
anisometropia has to get worse and affect the patient for decades to come.   
 
Treatment of Anisometropia 
 
Treatment for anisometropia is possible; however, the outcome for patients with higher 
degrees of anisometropia is worse.  Furthermore, there has been a correlation in the degree of 
anisometropia and the depth of amblyopia.  High degrees of anisometropia cause a difference in 
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the image size between the two eyes (this can lead to a condition known as aniseikonia, the topic 
of the current study).  Many studies suggest that a anisometropia level of more than 3.50 D 
creates a barrier to visual fusion: these patients may be left undercorrected with a small chance of 
improving their amblyopia.16,17   
 
Anisometropia and Aniseikonia 
 
As mentioned earlier, anisometropia is a visual condition in which a patient’s left and 
right prescriptions are unequal, this can be a result of a difference in refractive power, or axial 
length.  When a difference in axial length is the cause of a patient’s anisometropia (i.e. axial 
anisometropia), the result can leave the optical power unaffected.   Patients with axial 
anisometropia often have a refractive power of 2.00 D or greater.3,18 Furthermore, if the 
anisometropia causes a difference in retinal image sizes, then the condition might be classified as 
aniseikonia: it is possible for a patient to have differing retinal image sizes, and not be classified 
as aniseikonic. 
It is important to emphasize the difference between aniseikonia, and a basic difference in 
retinal image size.  For instance, a patient could have a difference in retinal image size, and 
experience no difference in cortical image size.  Aniseikonia relies on the fact that the patient is 
experiencing a difference in the perceived cortical image sizes of image due to the difference in 
retinal image size.  In addition, it possible for aniseikonia, and patients with differing retinal 
image sizes to occur in either corrected and uncorrected eyes.   
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Aniseikonia and Knapp’s Law 
 
Correction of aniseikonia can be achieved through prescription lenses. Knapp’s Law 
attempts determine the most appropriate type of prescription to diminish aniseikonia.  According 
to Knapp’s Law, it is possible to place spectacle correction at the anterior focal plane in order to 
equalize the retinal image sizes, but only in certain types of aniseikonia.  Knapp’s law states that 
if a correcting lens is placed before an axial ametropic eye so that its second principal point 
coincides with the primary focal point of the eye (~17mm), the resulting retinal image will be the 
same as that of an emmetropic eye.19 This correction method would not be sufficient for patients 
with refractive anisometropia; anisometropia relies on correction at the corneal plane of the 
spectacle magnification. Since Knapp’s time, contact lenses have made this possible for 
refractive anisometropes. 
Knapp’s Law is mathematically correct; however, it can fail in clinical practice.  Part of 
the law states that “the refractive power of the eye must be equal to that of the standard 
emmetropic eye,” this tenet of the law suggests that differing retinal image sizes resulting from 
refractive ametropia cannot be rectified with spectacle lenses. However, Knapp did not consider 
cortical magnification as a major factor in ansiekonia.20 For example, in amblyopia, the sound 
eye has often less hyperopia but greater cortical magnification. Because of this shortcoming 
implied by Knapp’s Law, contact lens correction has been offered to patients with both axial 
anisometropia and aniseikonia. Kowal et al. outline the method in which they prescribe contact 
lenses to spectacle wearing, myopic anisometropes in order to gauge their aniseikonic 
responses.3,21   
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Symptomatic Aniseikonia 
 
Anseikonia from anisometropia can often be difficult to identify, because patients that 
have these conditions, as well as corrective spectacles, often exhibit an adaptation to the different 
right and left cortical image sizes.  This adaptation is rare for patients with more than 5% 
aniseikonia, and the symptoms may even be suffered by patients with 3% or less.3,22 
Furthermore, Crone and Leuridan mean tolerances of 7%.  This value is the average residual 
aniseikonia in examples of a patients that have a unilateral aphakia corrected with contact 
lenses.3,23 That is primarily the reason that intraocular lens implants have the greatest potential to 
reduce the difference of perceived image sizes.   
When dispensing anisometropes with spectacles for the first time, it might be necessary 
to investigate the occurrence of aniseikonia; especially if the patient has good acuities in both 
eyes.  Sometimes, ophthalmic prisms are necessary if the patient’s fusion of the two images is 
hindered by their degree of aniseikonia.  It is important to remember that the curvature, thickness 
(t) and refractive index (n) of a lens will affect the shape factor element (F), given by one of the 
magnification lens (i.e.1 / [1-(t/n) F].3   
Another issue to assess and control is the instance of dynamic aniseikonia.  Dynamic 
aniseikonia is defined as “a heterophobia which varies in magnitude with prismatic effect as the 
eyes deviate from the optical center of the spectacle lens”.3,22 Dynamic aniseikonia is a 
consequence of Prentice’s rule applied to anisometropic corrective lenses. Combining spectacles 
with contact lenses and changing the vertex distance of spectacle frames are also ways to alter 
the magnification factor of the correcting system.   
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Diagnosing Aniseikonia 
 
Cases of aniseikonia have been noted for decades, originally defined by Walter 
Lancaster, who become head of the Dartmouth Eye Institute in 1940.24 During the 1930s and 
1940s, Dartmouth Eye Institute developed instruments to measure the minute differences in 
image size.  The work done by the Dartmouth Institute lead to the first treatment for symptoms 
related to aniseikonia.25 
Dating to this era, many researchers argued that the most effective way to diagnose 
aniseikonia is the Space Eikonometer. However, this long discontinued, bulky machine has been 
eclipsed by other forms of testing that have been developed and used more recently.26,7  Since the 
later 20th century, clinicians have been using the Maddox-rod based Brecher test, the double 
Maddox rod-based Miles test, as well as the “New Aniseikonia” (Awaya) plate test, and most 
recently, the Aniseikonia Inspector Software to determine the degree to which a patient has 
aniseikonia.25 Both the Brecher test and the Aniseikonia Inspector software were used in the 
present study. 
 
Causes of Aniseikonia 
 
Aniseikonia can theoretically be caused by many factors that also cause anisometropia, 
including differences in ocular size, axial length, refractive error, and retinal or neural 
distribution of photoreceptor cells and receptive fields, respectively.28 Retinotopic mapping is a 
process in which both eyes simultaneously create images from corresponding retinal points.  If a 
difference in eye size, or refractive power exists between the left and right eye, then a difference 
in the perceived size of the image will occur. Aniseikonia can also result when a longstanding 
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anisometropia for which the visual cortex is adapted is suddenly eliminated by monocular 
cataract surgery or monocular refractive surgery. Full monovision correction with contact lenses 
or surgery can also create aniseikonia. 
Aniseikonia can also be associated with oblique astigmatism, and commonly with retinal 
diseases such as epiretinal membrane and vitreomacular traction.28,29 There are several 
conditions and factors that may contribute to aniseikonia, but the focus of this study is to 
examine the effects of lenses specifically designed to mitigate the instance of aniseikonia, as well 
as non-aniseikonic lenses ability to address this condition.  In order to examine the variables in 
this study, more information must be provided on the two main types of aniseikonia. 
 
Consequences of Aniseikonia 
 
The way in which patients function with aniseikonia is an important topic of discussion in 
this study.  As stated previously, aniseikonia occurs when the cortex receives an image that is 
abnormally unequal to the two eyes in size, shape, or luminance.  In general, the brain can 
compensate for some degree of image inequality, including oblique aniseikonia; however, if the 
image inequality is severe, then stereoacuity will be impaired.30   
Aniseikonia is not necessarily the cause of amblyopia, but it is often associated with 
congenital or acquired anisometropia.  There have been frequent cases of aniseikonia related 
high anisometropia, such as unilateral aphakia, in the last few decades.  In some cases, the degree 
of aniseikonia has been reported to be as high as 35%.30 Considering the availability of contact 
lenses, and the development of intraocular lenses (IOLs), it is likely that aniseikonia can be 
avoided altogether.   
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Despite the widespread practice of refractive surgery, and prevalence of emmetropic 
pseudophakia, aniseikonia has been more frequently reported in patients after surgeries relating 
to corneas and cataracts. Haring et al. reports near-vision aniseikonia in up to 12% (mean 2.4%) 
of patients that were implanted with the first generation of multifocal IOLs.  In another study, 
Kramer et al. found that up 10% aniseikonia (mean 4.1%).31 Furthermore, a study investigating a 
population with pseudophakic patients, they report subjective complaints of aniseikonia at 
40.2%.31 Huber and Binkhurst also promote caution about aniseikonia induced by the 
implantation of anterior chamber IOLs for patients with high degrees of anisometropia.30,32 
Huber and Binkhursts’ findings show that aniseikonia is not a marginal problem, and that 
aniseikonia be considered with every anisometropia patient, especially anisometropia patients 
seeking lenticular refractive correction.   
Knapp’s law has the potential to provide corrective lenses and spectacles to remedy axial 
anisometropia without inducing aniseikonia.33 But as stated previously, this law lacks clinical 
evidence to support this correction.  Away and Von Noorden provide an explanation to the 
shortcoming of Knapp’s Law on the treatment of anisometropia; they argue that pure axial 
anisometropia is a rare condition, because it is commonly combined with the presences of 
refractive anisometropia (either corneal or lenticular).34 
The degree to which a patient has aniseikonia can be determined by many subjective 
measures, most often these results are observed in patients with unilateral cataracts or on 
psychophysical studies.  Other subjective methods of measurement are the phase-difference 
haploscope or the Space Eikonometer. With such subjective measurements, it is often difficult to 
record accurate measurements of aniseikonia in infants, and other young patients.35    
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Symptoms of Aniseikonia 
 
Aniseikonia is always the result of anisometropia—a binocular condition that manifests 
when patients’ traditional corrective lenses cause the eyes to perceive the same image as two 
different sizes. This size difference emerges in the occipital cortex in the occipital lobe, one of 
the four major cortices in the brain where the visual processing center resides.36 Aniseikonia 
results from the individual eyes to perceive unequal images when focusing.18 
This difference in the size of ocular images can lead to many effects on binocular vision. 
First, the binocular stereoscopic interpretation can be altered, if the disparity of the images 
relative to corresponding point and areas on the two retinas is atypical.18 Second, the difference 
in image size can cause problems with fusion; this can be a result of many symptoms discussed 
later in this study.  The amount of studies that report cases of anisometropia (approximately 
2.5%) necessitates further research into correction methods for patients with this condition.24,37 
 
Figure!1:!!Characteristic!symptoms!reported!by!500!patients!referred!for!aniseikonia!
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This negative corrective effect of anisometropia (or sudden iatrogenic anisometropia 
caused by cataract and refractive surgery) can lead to several symptoms (Fig. 1) that make vision 
a struggle for the patient.38 Though a patient is often diagnosed with both aniseikonia and 
anisometropia, because they often represent the cause and consequence of the same vision 
problem, the actual relationship between the two deficiencies has yet to be fully understood. For 
example, data from the 1940s indicates that diplopia is rarely a symptom.39 
Aniseikonia can manifest in patients in several different ways: these symptoms can range 
from being physical to optical to neurological.  The physiological symptoms that manifest in 
patients with aniseikonia include photophobia, amblyopia, as well as excessive tearing.  If a 
patient reports these symptoms, then the probability that the individual suffers from aniseikonia 
is relatively great, especially, if the patients relies on differing refractive corrections in each eye 
to obtain clear, single binocular vision.28 
Relatively few patients with aniseikonia report mobility difficulties due to diplopia. In 
addition, some patients can experience spatial distortions accompanied and impaired depth 
perception.  The effect that aniseikonia has on the depth perception (stereopsis) significantly 
impacts the ability of the patient to interpret monocular and binocular clues.40 Keratometry can 
offer insight into the causality of the anisometropia and the presence of aniseikonia.  For 
instance, if there is a significant difference in the patient’s corneal power and anisometropia is 
present, then it is likely that the difference is refractive power is the main cause of the 
anisometropia. Conversely, if the corneal powers are nearly identical then the cause of the 
anisometropia is likely due to the differing axial lengths of the patients’ eyes. According to the 
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traditional Knapp’s Law, axial length differences can be corrected with spectacle lenses ideally 
located at the anterior focus of the eye to produce equal retinal images sizes.28 
 
Congenital vs. Acquired Aniseikonia 
 
It is possible for anisometropia or aniseikonia in infancy or childhood to lead to 
irreversible impairment in later life; however, it is possible, in adults with unilateral aphakia, to 
restore binocular function with the use of contact lenses, specific sized lenses, intraocular lenses, 
or a combination of these methods.  In clinical studies, the level of aniseikonia in unilateral 
aphakia is reported to be approximately 20% when corrected with glasses, 10% when corrected 
with contact lenses, and only 2.5% with IOL implants.35,41 That said, the IOL performed well 
when it came to binocular function.   
In a particular study, the binocular system was capable of fusion of up to 3% aniseikonia, 
yet when aniseikonia reached or surpassed 5%, there was no significant binocular summation for 
any of the patients. In cases of high aniseikonia (8-10%) the monocular visual evoked response 
(VER) amplitudes were larger than the binocular VER. This might be attributed to the binocular 
inhibition due the large difference in the perceived retinal image size.35 Furthermore, it is likely 
that binocular function may be capable of visual fusion to compensate for the smaller difference 
in perceived retinal size; however, when the difference surpasses a certain level, fusion ceases 
and might instead result in binocular inhibition, resulting in the smaller binocular VER 
amplitude.   
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Treatment of Aniseikonia 
 
Since there is likely correlation between anisometropia and aniseikonia, the following 
guideline should be considered when attempting to correct these various types of anisometropia: 
1.! Pure axial anisometropia:  
a.! The first method for correction should be spectacles. 
b.! Cataract surgery is a possibility.  If this is the case, the goal should be to 
emmetropize the dominant eye. 
c.! IOLs can also remedy the problem.  The power of the IOL (in the surgical 
eye) should be the difference between the emmetropizing power in the 
surgical eye, minus the difference between both axial powers. 
2.! Corneal anisometropia: 
a.! Contact lenses 
b.! Refractive surgery 
c.! Cataract surgery. 
3.! Lenticular anisometropia: 
a.! The best form of correction would be cataract surgery (in older patients). 
b.! Refractive surgery can be more effective with younger patients. 
4.! Combined anisometropia: 
a.! The anisometropic components must be considered independently. 
b.! The balance of the induced aniseikonia must be calculated in regards to 
the surgeries considered as well as retinal causes (e.g. epiretinal 
membrane).   
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Traditionally, research has shown that the aniseikonic limit of the human visual system 
cannot exceed 2% difference between the images sizes of the two eyes; otherwise, fusion 
becomes too difficult for the binocular system to work properly.  Clinically, there is a “rule of 
thumb” that for every one diopter of corrected anisometropia results in 1% image size difference 
between the two eyes.24 In a study looking at the effect of stereopsis on aniseikonia, by using a 
random-dot stereogram, Oguchi and Mashima observed that between 3% and 5% of aniseikonia 
patients still experienced binocular summation, and also that stereopsis was present.24,42 
By modifying the magnification of the current ophthalmic spectacle lens technology it is 
possible to rectify aniseikonia. Achiron.et.al. apply five factors of aniseikonia correction: base 
curve, refractive index, center thickness, sagittal depth of contemporary aspheric lenses, and high 
index lenses, in order to reduce the size differences (<5%) to tolerable vision.24 
There are two main methods for aniseikonia correction: contact lenses and aniseiknoic 
spectacle lenses; however, the preferred form of treatment is contact lenses. In some cases, 
patients are unable to use contact lenses; therefore, in this study patients will be prescribed 
aniseikonic spectacle lenses. The procedures for prescribing the spectacle lenses to patients has 
traditionally depended on Knapp’s law.  
 
Study purpose  
 
The purpose of the study is to predict the base curve of the spectacle correction of the 
patients that will minimize their aniseikonia. By manipulating the base curve of the lens power 
from the subject’s prescription to change the magnification, without ultimately altering the 
prescription.  This will result in the correction of the patient’s aniseikonia.   
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MATERIALS!and!METHODS!
 
Research participants were recruited from current students, patients, and faculty at Pacific 
University College of Optometry in Oregon.  In this study there were 12 voluntary participants, 
including the author.  Besides the tests performed on the researcher of this study (which were 
carried out by the researcher’s thesis advisor) all test were performed by the researcher at two 
locations in Oregon: the Pacific University Eye Clinic in Forest Grove, as well as the Pacific Eye 
Clinic, Portland.  The mean age of the 12 participants was 29.60 (SD of 7.69), all participants 
were female, and had an ocular history of anisometropia with a spherical equivalent of ≥ 1 
D.  The participants were evaluated for anisometropia while wearing their habitual correction 
(i.e. non-size lens) and reassessed 2-6 weeks later.  All subjects were tested twice, and the total 
time for both visits was approximately two hours.   All participants were recruited between 
February through June, 2016. 
To be considered for this study, participants must have met all the inclusion 
criteria.  Participants had to be 18 years of age or older, they had to have anisometropic spherical 
equivalent of ≥ 1 D, and regardless of the cause of the anisometropia. They had to have visual 
acuity of 20/25 or greater corrected vision.   
The following is a description of the procedures that took place during the two visits that 
the 12 participants underwent.  In the first visit, participants were interviewed about the medical 
and ocular history.  Next, the participants had their ocular refraction measured, with an A-scan 
ultrasound biometry with topical anesthetic eye drops (0.5 % proparicaine), and a keratometry 
measurement. In addition to the preliminary interview and measurements, the participants 
completed a series of test to assess their stereopsis, their level of anisometropia, as well as their 
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visual acuity of their corrective vision.  The participants’ stereopsis was measured by the 
Random Dot E Test. Figure 2 showed all the materials used in the previous steps. The 
aniseikonia was measured by the Brecher Test (Appendix A) as well as, by use of the 
Aniseikonia Inspector Software test (Appendix B). The last task of the first visit was a 
questionnaire to measure the presence or severity of the symptoms commonly experienced by 
patients with aniseikonia impairment. The scale for the questionnaire was from 0-10: zero 
indicated the participant did not experience the symptom, and ten indicated that the symptom 
was experienced with the most severity (Appendix C). 
 
 
Figure!2:!!Examination!materials!used!in!the!study!
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Size lens spectacles were prescribed according to the findings of the first visits with new 
frames provided by the researcher.  The researcher used two base curves.  The first base curve 
was 2 D (the flattest base curve was used for most plus or least minus) and the second base curve 
was 6 D (steepest base curve used for most minus, or least plus).  These spectacles lenses were 
the most readily available, and came premade (“stock”) by the manufacturing optician, and were 
prepared for edging and framing.  It is important to emphasize that lenses changed the optical 
magnification properties of the spectacle lenses without affecting the original prescription.  All 
lenses were edged at Pacific University Optical Dispensing Lab in Forest Grove, Oregon, by the 
researcher with new glasses frames.  Size lens spectacles were given to the subjects to be used 
full time; participants could wear their contact lenses for one hour per day for any sport activity. 
All subject had a follow up visit after 2-6 weeks.       
The second visit was a way to assess the efficacy of the size lenses that were issued after 
the first visit.  After the participants had worn their size lenses for 2-6 weeks the same test 
carried out in the first visit were re-administered.  The participants were asked to describe their 
experiences with the spectacles and underwent a visual acuity test, as well as a stereopsis 
measurement via the Random Dot E Test. Participants were assessed for horizontal aniseikonia 
via the Brecher Test and the Aniseikonia Inspector software test and their phoria compensated 
using the loose prism if needed. Lastly, participants were asked to reevaluate their symptoms and 
severity via the symptom questionnaire.  After both visits, participants were allowed to keep their 
spectacles with size lenses. 
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Statistical Analysis  
 
For descriptive demographic characteristics of the study sample and calculated change in 
size per diopter of base curve change, Brecher and AIS; means, median, mode, range and 
standard deviations (SD) were used. For comparison of anisometropia and aniseikonia values 
between the three lenses (habitual spectacle, size lens spectacle (without prism) and size lens 
spectacle with prism), one-way analysis of variance (ANOVA) and the Tukey honest significant 
differences test for global comparisons among means were used. Differences were considered 
statistically significant for an > value of 0.05 (p = 0.05). Data correlations were determined using 
linear regression analysis and the Pearson product moment correlation coefficient was calculated. 
For comparison aniseikonia mean of habitual spectacle and size lens spectacle with Brecher test 
and AIS test, t-test significant differences test for global comparisons among means was used. 
For comparing symptoms, one-way ANOVA, each of the all individual symptom scores was 
compared between the three lenses (habitual spectacle, size lens spectacle without prism and size 
lens spectacle with prism.  
 
!
!
!
!
!
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RESULTS!
!
Thirteen patients met the inclusion criteria and were enrolled in the study. Three patients 
were excluded from the analysis because of incomplete follow-up. Ten subjects (all females), 
aged 23 to 48 years, completed the study. For their habitual optical correction, 8 patients used 
glasses, 1 patient used contact lenses and 1 used progressive glasses. Table X showed the 
demographic characteristics of the sample. 
 
Table!1:!!Demographic!characteristics!of!the!study!population!
Variable N Mean ± SD Range 
Age 10 29.60 ± 7.69 23.00 to 48.00 
Sphere 10 2.15 ± 4.16 -8.88 to 3.25 
Cylinder 10 0.89 ± 0.87 2.50 to 0.00 
AL 10 24.00 ± 1.62 21.34 to 26.17 
K_reading 10 44.13 ± 1.42 41.50 to 46.38 
Spherical Equivalent 10 3.03 ± 4.12 -10.13 to 2.63 
Anisometropia 10 1.96 ± 0.76 0.75 to 3.00 
N= sample size, SD = standard deviation 
AL = axial length differences between two eyes, 
K_reading = keratometry reading differences between two eyes 
 
 
Medical History and Size Lens Spectacle Experience 
 
All subjects had no known medical history. Sixty percent of the subjects reported some 
discomfort using the size lens spectacles on the first day. Eighty percent of the population felt 
they are comfortable more with the size lens spectacle than their habitual spectacle especially for 
headache and reading difficulty on the following days. The remaining subjects did not feel any 
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difference between the two spectacles. Seventy percent of the subjects complained of 
photophobia with the size lens spectacles. 
 
Refractive Error Types and Anisometropia 
 
Table!2:!!Anisometropia!type!and!frequency!
Anisometropia Type Frequency Percent 
Axial 7 70.0 
Mixed 3 30.0 
Refractive 0 0.0 
Total 10 100.0 
 
As shown on Table 2, the most frequent anisometropia type of the study population was 
axial (7 subjects) followed by the mixed type (3 subjects). Four of the subjects were hyperopic 
while the other six subjects were myopic. Six participants had a refractive error combined with 
astigmatism. 
 
Visual Acuity and Stereopsis 
 
Table!3:!Comparison!of!visual!acuity!and!stereopsis!in!visit!1!and!2!
Variable N Mean SD t df P 
Visual Acuity 
Habitual spec.  10 0.78 0.17 
5.09 9 0.000 
Visual Acuity 
Size lens spec. 10 0.99  0.15 
Stereopsis 
Habitual spec.  10 52.05 58.92 
1.00 9 0.343 
Stereopsis Size 
lens spec. 10 51.30 59.42 
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Best-corrected visual acuity before used size lens spectacle averaged 20/28 in each eye 
(range, 20/40 to 20/20) and 20/20 in each eye (range, 20/25 to 20/15) after used size lens 
spectacle. 
Table 3 presents the findings of a paired sample t-test to visual acuity, that found 
statistically significant differences between the habitual spectacle and size lens spectacle (P= 
0.00< 0.05, t=5.099, df=9), as (mean ± SD)  habitual spectacle (0.78 ± 0.17), while (0.9975 ± 
0.15) to size lens spectacle. Also show the stereopsis in the visit 1 ranged from 12.50 to 160.00 
sec of arc  (mean [± SD], 52.05 [± 58.93]  , wherever stereopsis in visit 2 ranged from 12.50 to 
160.00 sec of arc  (mean [± SD], 51.30 [± 59.42]. The findings of a paired samples t-test, that 
found no statistically significant differences in the stereopsis (P= 0.343> 0.05, t=1, df=9) as 
mean stereopsis on visit 1was 52.05 while mean stereopsis on visit 2 was 51.30. We found 
stereopsis reduced in visit 2, but there is enough evidence to conclude that there is not a 
difference in the mean stereopsis of the two visits. 
 
Axial Length and Anisometropia 
 
Table!4:!!Prediction!of!anisometropia!spherical!equivalent!by!eye!axial!length!
Model 
Unstandardized 
Coefficients R R2 t Sig. B Std. 
Error 
 (Constant) 1.603 0.218 0.713 0.508 7.353 0.000 AL_difference* 0.409 0.142 2.875 0.021 
* AL_difference = axial length differences between two eyes 
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Table 4 presents the findings of prediction of anisometropia spherical equivalent (SE) 
differences between two eyes by axial length differences, that found R= 0.713, and R2= 0.508, 
the equation to predict the axial length and spherical equivalent relationship was: 
 Anisometropia SE difference between two eyes = 0.409 * AL_difference (mm) + 1.603 
This result shows a good model of predication about the relationship between the axial 
length and anisometropic SE difference between the two eyes (Fig. 3) 
 
 
Figure!3:!!Prediction!of!anisometropia!spherical!equivalent!by!axial!length!
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Aniseikonia test 
 
a.! Brecher test 
Table!5:!!Comparison!of!aniseikonia!mean!of!habitual!spectacle!and!size!lens!spectacle!with!
Brecher!test!
Variable N Mean ± SD t df P 
Habitual spec. 10 3.10 ± 0.76 
6.273 9 0.000 Size lens spec. 
(without PRISM) 10 0.8 ± 1.22 
Habitual spec. 10 3.10 ± 0.76 
8.333 9 0.000 Size lens spec. 
(with PRISM) 10 0.20 ± 0.42 
 
Table 5 presents the findings of a paired samples t-est to Aniseikonia test with Brecher, 
that found statistically significant differences between the Bercher habitual spectacle and 
Bercher size lens spectacle without prism (P= 0.00< 0.05, t=6.273, df=9) as mean Bercher was 
0.80 % without prism, while mean Bercher to habitual spectacle was 3.10 %, and illustrated that 
mean Bercher in size lens spectacle without prism was 0.80 % greater than mean Bercher in size 
lens spectacle with prism was 0.20, that means aniseikonia test is a lot better with Bercher size 
lens spectacle with prism (Fig. 4). 
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Figure!4:!!Aniseikonia!mean!of!different!spectacles!with!Brecher!test!
 
 
b.! Aniseikonia Inspector Software (AIS) 
Table&6:!!Comparison!of!aniseikonia!percentage!of!habitual!spectacle!to!size!lens!spectacles!
with!Aniseikonia!Inspector!Software!(AIS)&
Variable Mean ± SD t df P 
Habitual spec. 2.40 ± 2.17    
Size lens spec. 
(without PRISM) 1.40 ± 1.17 
 
1.627 
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0.138 
Contact lens 0.90 ± 1.52 2.09 9 0.067 
Size lens spec. 
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Table 6 presents the findings of a paired sample t-test to aniseikonia test with Aniseikonia 
Inspector Software (AIS), that found statistically significant differences between the AIS 
habitual spectacle and AIS size lens spectacle with prism (P= 0.00< 0.05, t=3.29, df=9) as mean 
AIS size lens spectacle  =  0.10 with prism, while mean AIS  to habitual spectacle = 2.40, and 
illustrated that mean AIS in size lens spectacle without prism =1.40 greater than mean AIS in 
size lens spectacle with prism  = 0.10, that means aniseikonia test is better a lot with AIS size 
lens spectacle with prism shown in Figure 5.  
 
 
Figure!5:!Aniseikonia!mean!of!different!lenses!with!AIS!test!
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Figure!6:!Means!of!anisometropia!and!aniseikonia!of!different!correction!with!Brecher!and!AIS!
tests!
 
Symptoms 
 
Table!7:!!Comparison!of!symptom!scores!at!each!visit!(habitual!spectacle,!contact!lens!
Symptoms 
Habitual  
Spectacle 
Contact 
Lens  
Size lens 
spectacle F P 
Mean ± SD Mean ± SD Mean ± SD 
Headache 5.40 ± 7.152 4.80 ± 7.330 1.80 ± 3.676 0.943 0.402 
Asthenopia 2.50 ± 1058 2.20 ± 1.99 1.00 ± 1.41 2.235 0.126 
Photophobia 0.50 ± 0.71 0.20 ± 0.42 0.80 ± 1.48 0.946 0.401 
Reading Difficulty 4.70 ± 10.39 7.80±13.89 0.33 ± 0.71 2.988 0.067 
Others 0 0 0 - - 
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Table 7 presents the findings of symptom scores at each study habitual spectacle, contact 
lens and size lens spectacle), that there were no statistically significant differences between 
(habitual spectacle, contact lens and size lens spectacle) of each symptom: headache 
(F(2,27)=0.943, p=0.402>0.05), asthenopia (F(2,27)=2.235, p=0.126>0.05), photophobia 
(F(2,27)=0.946, p=0.401>0.05), reading difficulty (F(2,27)=2.988, p=0.067>0.05), Others (no 
variance), so there is enough evidence to conclude that there is no difference in the mean of all 
symptom to three measurement (habitual spectacle, contact lens and size lens spectacle). 
Clinically, the mean of subjects symptoms score shows significant improvement with size lens 
spectacle for headache, asthenopia and reading difficulty (Fig. 7). 
 
&
Figure!7:!Subject!symptoms!with!each!type!of!lens 
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Base curve change and Aniseikonia % change 
 
Table!8:!!Aniseikonia!percentage!change!per!base!curve!diopter!
  BC change Brecher  AIS  Change in size per diopter 
 D % % Brecher % AIS % 
N 10 10 10 10 10 
Mean ± SD 1.65 ± 1.87   2.80 ± 1.14 2.10 ± 1.79 0.878 ± 0.66 0.691 ± 0.79 
Median 0.75 3 1.5 0.75 0.39 
Mode 0 3 1 0.75 0.25 
BC change = spectacle base curve difference between habitual spectacle and size lens spectacle 
AIS = aniseikonia inspector software 
 
Table 8 presents the findings of base curve change per diopter change in size, that found 
Mean ± SD to diopter change in size for Brecher (0.878 ± 0.66), and (0.691 ± 0.79) to diopter 
change in size for Aniseikonia Inspector Software (AIS). So every 1.00 D in spectacle base curve 
change will correct around 0.785 % (mean average of Brecher and AIS tests) 
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DISCUSSION!
 
Primarily, our study aims to provide better understanding of aniseikonia and how to treat 
it clinically with different methods (e.g. contact lenses). Aniseikonia can occur either as a 
difference in axial length or corneal power or both, as shown by our results.  
Based on the finding observed on the first visit, we found that anisometropia spherical 
equivalent of ≥ 1 D cause aniseikonia of at least 1%. Also, anisometropia spherical equivalent 
resulted from the difference in axial length between the two eyes regardless the refractive error 
or anisometropia type according to the prediction equation (Fig. 3). This challenges the clinical 
rule of thumb that for every one millimeter of axial length difference between the two eyes 
results in 3 D of anisometropia.  
Based on the result of the second visit, visual acuity improved one line with size lens 
spectacles. Stereopsis was not affected for all subjects except one who showed improvement 
from 20 to 12.5 sec of arc. We attribute this finding to the improvement of the image quality but 
we still do not know the exact effect of the size lens spectacles on stereopsis.  
Our results showed that the size lens spectacles improved the aniseikonia, but the 
improvement is limited with most subjects by the Brecher and Aniseikonia Inspector software 
(AIS) tests. We discovered after the first two subjects that when we compensate the subjective 
phoria, all subjects except one reached zero percentage with both aniseikonia tests. After the 
third participant, we neutralized any subjective phoria by loose prism, as needed. We discovered 
that there was significant improvement of both aniseikonia tests with the prism. Aniseikonia 
measurement with size lens spectacles was easier to neutralize with the Brecher test than AIS, 
that could be because the AIS is more precise than Brecher. This result gives us a suggestion 
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clinically to measure the anisometropic patient’s phoria before prescribing any size lens 
spectacles. Yet we cannot explain the optics by which the image sizes were corrected, except 
perhaps by using the SILO (Smaller In, Larger Out) effect. That is, base in prism magnifies the 
bionocular image, and base out minifies it. We were unsuccessful in finding a relationship 
between refractive error and the corrective prism base direction, but no clear pattern emerged. 
For example, hyperopes in this study (n=4) did not routinely accept minifying BO prism, despite 
binocular spherical lens magnification. Similarly, myopes (n=6) in this study did not accept 
magnifying (BI) prism despite binocular lens minification. 
There were no statistically significant difference of the symptoms between habitual 
spectacles, contact lenses and size lens spectacles, but there is a clinically-significant improvent 
of headache, asthenopia and reading difficulity with size lens spectacles compared to habitual 
spectacles and contact lenses. This is most probably due to the correction of the cortical image 
size. Comparing size lens spectacles to habitual spectacles, rates of headache decreased by 66.7 
% and severity improved from severe to mild on the symptom scale (Fig. X). Incidence of 
asthenopia decreased by 60% and its severity improved as well. Surprisingly, severe reading 
difficultiy decreased by 93%, and some patients had almost no difficulty (mean = 0.33). 
However, reading difficulty increasing by 40% for contact lenses compared to habitual 
spectecles. We think that a possible explanation for the improvement of the headeche, asthenopia 
and reading difficultiy was that we neutrlized the image size between the two eyes, which 
diminished binocular vision interference, by improving anieskonia and vision quality.   
On the other hand, photophobia rates increased by 60 % with size lens spectacles 
compared to habitual spectacles, which are expected due to the fact that no antireflective 
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coatings were used for these lenses. More studies are required to compare the aniseikonia 
amount when treated by size lens spectacles and prism. 
 
0 1-2 3-4 5-6 7-8 9-10 
No symptoms Mild Moderate Severe Very severe Worst 
 
Figure!8:!Subject!Symptoms!Scale!
 
In order to minimize each subject’s aniseikonia, we compare the subject’s habitual 
spectacle base curve to size lens spectacle base curve difference (4 D) and the aniseikonia 
amount (Appendix D). We found that the mean average of the two aniseikonia tests is 0.7845 % 
per one diopter of anisometropia spherical equivalent. We do not think that we can generalize 
this as a clinical rule due to the small sample size, but future studies may need to establish a 
more precise rule-of-thumb than the traditional 1D of anisometropia equaling 1% aniseikonia. 
Subjects who used plastic frames were more comfortable than subjects who use metal frames 
regardless of their type of refractive error. It might be that the subjects using the metal frames 
suffer from awareness of the lens edge thickness more than who used the thicker plastic frames. 
This was indicated by one subject who had a better visual experience when her frame was 
changed from metal to plastic. 
There are a few limitations to our study. First, the sample size was small. Second, we do 
not know the relation between the improvement of aniseikonia and the prism effect. 
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CONCLUSION!
 
Size lens spectacles are a good option for patients who have axial or mixed 
anisometropia. Every 1.00 D change in the base curve of spectacle lenses between right and left 
lenses will correct approximately 1 % of the aniseikonia. Center thickness and refractive index 
also are important factors need to be examined in relation to base curve change in spectacles 
between right and left lens for different refractive errors. Further studies are necessary to show 
the effect of prism on aniseikonia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
35 
 
REFERENCES!
1.! Harvey W, Gilmartin B. Pediatric Optometry. Edinburgh: Elsevier, 2004; p. 8 
2.! Weale RA. Age-related prevalence of anisometropia. Ophthal Res. 2002; 34, 389–92  
3.! Paul M. Anisometropia. What difference does it make? Anglia Ruskin University, 
Cambridge, Optometry in Practice. 2013; Volume 14 Issue 1 1 – 10. 
4.! Woodhouse M. Development of visual functions II. Optom Today. 2012; 41  
5.! Hadi O, Akbar F, Hassan H,Abbas AY,  Javad H,  Bahareh H, Ebrahim J, Farhad R, 
Mehdi K. The Prevalence of anisometropia in population base study. 2012; strabismus, 
20(4), 152–157. 
6.! Maths A, Johan S. Natural history of infantile anisometropia. British Journal of 
Ophthalmology 1996; 80: 860-863. 
7.! Von Noorden G. Binocular Vision and Ocular Motility, 4th edn. CV Mosby: St Louis, 
1990; pp 208–213 
8.! Birch E, Stager D, Everett M. Natural history of infantile anisometropia. Invest 
Ophthalmol Vis Sci 1995; (suppl 36):845.  
9.! Roberts. C.J & Adams, G. Contact lenses in the management of high anisometropic 
amblyopia: Eye (2002) 16, 577–579 
10.!Mark B, Kristina T, DPhil, Susan A. C, Ning L, Stanely P. A, Rohit V, the MEPEDS 
study group. Anisometropia in infants and young children: Prevalence and risk factors 
from the multi-ethnic pediatric eye disease study: Published in final edited form 
as:Ophthalmology. 2010; 117(1): 148.  
11.!Eva KL. Development of astigmatism and anisometropiain preterm children during the 
first 10 years of life: A population-based study. 2006; ARCH ophthalmol /vol 124 
12.!Brendan TB, Arthur B, Rowan C. The relationship between anisometropia and 
amblyopia. Progress in Retinal and Eye Research. 2013; 120-158.  
13.!Qin, X.J., Margrain, T.H., To, C.H., Bromham, N., Guggenheim, J.A. Anisometropia is 
independently associated with both spherical and cylindrical ametropia. Investigative 
Ophthalmology & Visual Science 2005; 46:4024-4031.  
14.!Tomac S, Birdal E. Effects of anisometropia on binocularity. J Pediatr Ophthalmol 
Strabismus. 2001;38:27–33.  
15.!Huynh SC, Wang XY, Ip J, et al. Prevalence and associations of anisometropia and 
anisoastigmatism in a population based sample of 6 year old children. Br J Ophthalmol. 
2006;90:597–601.  
36 
 
16.!Flynn JT, Woodruff G, Thompson JR, Hiscox F, Feuer W, Schiffman J et al. The therapy 
of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two 
pooled data sets. Trans Am Ophthalmol Soc 1999; 97: 373–390. 
17.!Hiscox F, Strong N, Thompson JR, Minshul C, Woodruff G. Occlusion for amblyopia: a 
comprehensive survey of outcome. Eye 1992; 6: 300–304. 
18.!Bradley J, Rabin RD, Freeman. Nonoptical determinants of aniseikonia; Investigative 
Ophthalmology & Visual Science. 1983; 24:507-512.  
19.!Cline, D., Hofstetter, H. W., & Griffin, J. R. Dictionary of Visual Science. Radnor: 
Chilton Trade; 1989. 
20.!Kramper P, Shippman S, Meininger D, Lubkin V. A study of aniseikonia and Knapp's 
law using a projection space eikonometer. Binocular Vision & Strabismus Quarterly 
1999; 197-201.  
21.!Kowal L, Battu R, Kushner B. Refractive surgery and strabismus. 2005;Clin Exp 
Ophthalmol 33, 93  
22.!De Witt GC. Retinally-induced aniseikonia, optical diagnosis. 2007; Eikvaren 19, 3–5. 
23.!Crone RA, Leuridan OMA.Tolerance for aniseikonia. Graefes Arch Klin Exp 
Ophthalmol 1973;188, 1–16. 
24.!Achiron, L.R., Witkin, N. & Primo, S. Broocker G.Con temporary management of 
aniseikonia. Surv Ophthalmol. 1997 ; 41(4): PP 321-30. 
25.!Brandon R. Aniseikonia: A case series and literature review, College of Optometry 2011. 
26.!Antona, B, Barra F, Barrio A, Gonzalez E, Sanchez I. The Validity and Repeatability of 
the new aniseikonia test. Optometry and Vision Science 2006; 903-909.  
27.!McCormack G, Peli E, Stone P. Differences in tests of aniseikonia. Investigative 
Ophthalmology and Visual Science 1992. Science, Vol. 33, No. 6: 2063–7. 
28.!Ugarte M. Williamson. Aniseikonia associated with epiretinal membranes; Br J 
Ophthalmol 2005; 89: 1576–1580.  
29.!Phillips C. Strabismus, anisometropia, and amblyopia. British Journal of Ophthalmology, 
1959; 449-460. 
30.!Gobin L, Rozema JJ, Tassignon MJ. Predicting refractive aniseikonia after cataract 
surgery in anisometropia. J Cataract Refract Surg. 2008 Aug; 34(8):1353-61. 
31.!HaringG, GronemeyerA, HedderichJ, deDeckerW. Stereoacity and aniseikonia after 
unilateral and bilateral implantation of the Array refractive multifocal intraocular lens. J 
Cataract Refract Surg 1999; 25:1153–1156. 
32.!Huber C, Binkhorst CD. Iseikonic lens implantation in anisometropia. Am Intra-Ocular 
Implant Soc J 1979; 5:194–202. 
37 
 
33.!Romano PE, von Noorden GK. Knapp’s law and unilateral axial high myopia. Binocul 
Vis Strabismus Q 1999; 14:215–222. 
34.!Awaya S, von Noorden GK. Aniseikonia measurement by phase difference haploscope in 
myopic anisometropia and unilateral aphakia (with special reference to Knapp’s law and 
comparison between correction with spectacle lenses and contact lenses). Binocul Vis 
Strabismus Q 1999; 14:223–230. 
35.!Osonnu K, Tsuyoshi T, Totsuo H. Effect of Aniseikonio on binoculor Function. 
Investigative ophthalmology and visual science.1986;  vol. 27.  
36.!Spark Notes: Brain Anatomy: Parietal and Occipital Lobes: 2007-12-31. Retrieved 2008-
02-27. 
37.!Grosvenor TP, Flom MC. Refractive anomalies: Research and clinical Applications 
Editors 1991.  
38.!Bannon R, Triller W. Aniseikonia- A clinical report covering a ten year period. American 
Journal of Optometry 1944. 21; PP 171-182. 
39.!Bannon R. Clinical manual on aniseikonia. Buffalo, NY: American Optical Corporation. 
1954  
40.!Linksz A. Bannon Re. Aniseikonia refractive problems.; Int ophthalmol clinic 5 1965; PP 
515-534. 
41.!Highman Vn. Stereopsis and aniseikonia in uniocular aphakia. BrJ Ophthalmol 1977; 
61:30. 
42.!Oguchi Y, Mashima Y: The influence of aniseikonia on the VEP by random-dot 
stereogram. Acta Ophthalmol 1989; 67:127- 130. 
43.!Brecher, G. New method for measuring Aniseikonia. American Journal of 
Ophthalmology 1951; 1016- 1021. 
 
44.!Amos JF. Anisometropia and Aniseikonia. In: J. F. Amos, Diagnosis and Management in 
Vision Care 1987. (p. 191).  
 
45.!De Wit G. User's Manual Aniseikonia Inspector. Optical Diagnostics 2008. Note: 
update2012 
 
46.!Ian G. Morgan; Kathryn A. Rose; Wayne Smith, George Burlutsky; Paul Mitchell; 
Seang-Mei Saw. Myopia, Lifestyle, and Schooling in Students of Chinese Ethnicity 
in Singapore and Sydney. 2008; Arch Ophthalmol. 2008;126(4):527-530. 
 
 
38 
 
APPENDIX!
!
A. Brecher Test43 
 
This test is named after Dr. Brecher after he originally described the procedure in 1951.  The 
test itself is rather simple.  Two penlights, a Maddox rod, and a few hand-held a focal 
magnifiers, or size lenses, are the only materials needed.  The examiner holds the penlights a set 
distance apart and points them at the participant; while the participant holds the Maddox rod over 
their right eye with the axis at 180 degrees (Fig. 9, A).  
The examiner instructs the participant to determine the location of the two red lines in 
relation to the penlights.  If the red line bisects a penlight, then this is considered zero-percent 
aniseikonia (Fig. 9, B). The participant has heterophoria if both red lines seen are shifted to one 
side; this can be compensated for using loose prism (Fig. 9, C and D).  However, if the red lines 
do not coincide with the distance between the penlights, then the iseikonic lens is shifted over the 
opposite eye, this allows for a quantifiable result in percentage form.  If the process is repeated 
with the Maddox rod at an axis of 90 degrees, the examiner can quantify vertical aniseikonia.  It 
has been reported to be as accurate as 0.5%.44 This procedure can also be done with the Maddox 
rod at axis 90 degrees in order to quantify vertical aniseikonia. 
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Figure!9:!!Bercher!Test!
 
 
B. Aniseikonia Inspector Software test45 
 
The following is a description of the Aniseikonia Inspector Software used to measure 
participants’ horizontal aniseikonia.  The Aniseikonia Inspector is a direct-comparison 
eikonometry test.  Participants wear anaglyphic glasses (green-red lenses) and are then asked to 
assess if two rectangular boxes are of equal size.  The word eikonometry refers to the 
measurement of aniseikonia by displaying different sized images to each eye while wearing 
anaglyphic glasses and presentations.   
During both visits, computerized software will be used to measure the retinal image size 
differences, or the level of aniseikonia in each participant.  To carry out the test, participants are 
positioned in front of a monitor at a distance of approximately 40 cm wearing the anaglyphic 
glasses.  To calibrate the test, participants must align a straight vertical and horizontal line.  The 
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calibration was a control for fixation disparity.  Participants are asked to look through anaglyphic 
filters that are placed over their respective spectacles, and look directly at a target on the monitor 
in front of them. For each comparison, they choose the largest test target by pressing the 
corresponding arrow key, or ‘E’ if the images are equal (Fig. 10).   
 
 
Figure!10:!!A!subject!performing!the!Aniseikonia!Inspector!Software!test!
!
The result is given as a positive or negative percentage; the positivity or negativity of the 
measure is in reference to the right eye (Fig. 11).  The software instructions state: “The more 
inconsistent responses the patient makes, the less accurate the aniseikonia value may be. As a 
rough guide an inconsistency value of 3, 4, or more should trigger you to look at the raw data, 
possibly reinstructing the patient and repeating the test.” 
For more information, see the website: 
(http://opticaldiagnostics.com/products/ai/index.html) 
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Figure!11:!Aniseikonia!Test!result!sheet!“Horizontal![%]!column!used!in!this!study”!
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C.! Examination Form 
 
 
Figure!12:!!Examination!form!used!in!the!study!
 
 
 
D.! Steps to Calculate the Base Curve (BC) and Aniseikonia Relationship: 
 
1.! Calculate the OD – OS BC in habitual spectacle. Keep sign convention + or -. 
2.! Calculate the OD – OS BC in size lens spectacle. Keep sign convention + or -. 
3.! Subtract #1 from #2. This is the net BC change  
4.! Calculate change in aniseikonia from Brecher or AIS software (pre – post) 
5.! Divide #4 by #3. Equal to aniseikona amount per BC diopter 
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E.! Glossary 
 
 
AL Axial length  
ANOVA Analysis of variance 
D Diopter 
df Degree of freedom  
‘E’ Enter  
F distribution variable  
IOL Intraocular lens 
K_reading keratometry reading  
N Sample size  
OD Right eye 
OS Left eye 
P p-value  
R Sample Correlation coefficient  
R2 Multiple correlation coefficien  
ROP Retinopathy of prematurity 
SD Standard deviation 
SE Spherical equivalent 
Sig. Significance  
Spec. Spectacle  
t Student’s t variable  
VER Visual evoked response 
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Table&9:!Profile!and!clinical!characteristic!of!subjects!(1)!
Subject 
NO. 
Age Eye Refraction SE Anisometropia 
AL 
Dif. 
K. 
Dif. 
Anisometropia Type Base Curve Base Curve VA VA 
 Y   D D mm D  D D   
         Habitual spectacle 
Size Lens 
spectacle 
Habitual 
spectacle Size Lens spectacle 
1 23 
OD - 3.25 – 1.00 X 35 -3.75 
0.75 -0.95 -0.25 Axial 
1 2 20/25 20/25 +3 
OS - 4.50 DS -4.5 1 6 20/25 20/25 +2 
2 28 
OD -5.75 – 1.00 X 05 -6.25 
1.625 -0.75 -0.62 Mixed 
2.5 2 20/25 -2 20/20 
OS -6.75 – 0.75 X170 -7.875 2.5 6 20/25 -2 20/20 
3 29 
OD Pl – 0.25 X 180 -0.125 2.75 -1.39 -0.5 Axial 1 6 20/25 20/20 
OS + 3.00 – 0.25 X 65 -2.875     1 2 20/30  20/25 
4 26 
OD - 2.25 – 0.50 X175 -2.5 2.375 -1.02 -0.12 Axial 1.5 6 20/40 20/15 
OS Plano -0.125     1.5 2 20/25 20/25 
5 25 
OD + 1.5 -1.25 X170 -0.875 1.125 0.78 0 Axial 3 6 20/20 20/15 -1 
OS + 2.5 -1.00 X180 2     2.5 2 20/25 20/15 -2 
6 29 
OD + 3.25 – 1.25 X 160 2.75 2.625 -2.81 -0.25 Axial 5 2 20/40 +2 20/30 -2 
OS + 1.00 – 2.00 X 170 -0.125     2.5 6 20/20 20/20 
7 48 
OD - 6.50 – 1.75 X 176 -7.375 
1.25 0.87 0.5 Mixed 
2 6 20/30 -1 20/20 
OS - 5.25 – 1.75 X 05 -6.125 2.5 2 20/30 -1 20/20 
8 25 
OD -7.75 -2.5 X 178 -9 2.25 
 
-1.63 -0.25 Axial 
1 2 20/30 +2 20/20 
OS -10 -2.5 X 175 -11.25 1 6 20/25 -2 20/20 
9 25 
OD - 2.00 – 0.25 X106 -2.125 
1.875 0.69 1 Mixed 
1 2 20/20 20/20 +2 
OS - 4.00 -4 1.5 6 20/20 20/20 +2 
10 38 
OD + 3.25 3.25 
3 -2.57 -0.95 Axial 
2 2 20/25 20/20 +2 
OS + 0.25 0.25 2 6 20/20 20/20 +2 
OD = right eye, OS = left eye, SE = Spherical Equivalent, AL difference = AL difference between OD and OS, K.  differences = keratometry reading difference between between OD and OS, VA = visual acuity 
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Table&10:!Profile!and!clinical!characteristic!of!subjects!(2)!
Subject Lens Type 
Stereopsis  Aniseikonia  test % Symptoms  score 
Rondot 3 Brecher AIS prism Headache Asthenopia Photophobia Reading Difficulty Others 
“sec arc” Without Prism Without Prism       
1 Habitual spec. 20 3 6  4 4 0 0 0 
 CL NA NA 0  2 4 0  0 
 Size lens spec. 12.5 0 3* 10 BI 0 0 4 0 0 
2 Habitual spec 32 3 0  3 3 1 4 0 
 CL NA NA 0  2 3 1 4 0 
 Size lens 32 1 0 NA 0 2 3 0 0 
3 Habitual spec 160 3 1  2-3 4 0 3-4 0 
 CL NA NA 4  2-3 4 0 3-4 0 
 Size lens spec. 160 3* 2* 5 BI 1 2 0 0 0 
4 Habitual spec 16 2 2  2 3 1 3 0 
 CL NA NA   2 4 1 3 0 
 Size lens spec. 16 1 0 NA 2 2 1 2 0 
5 Habitual spec 32 2 1  1-2 0 0 0 0 
 CL NA NA NA  1-2 0 0 0 0 
 Size lens spec. 32 0 2* 4 BI 1-2 0 0 0 0 
6 Habitual spec 63 4 4  0 3 0 2 0 
 CL NA NA 2  0 2-3 0 3 0 
 Size lens spec. 63 0 3* 2 BO 0 2-3 0 0 0 
7 Habitual spec 12.5 3 1  0 1 1 2 0 
 CL NA NA 0  NA NA NA NA NA 
 Size lens spec. 12.5 0 2* 3BI 0 0 0 1 0 
8 Habitual spec 12.5 3 2  0 0 2 0 0 
 CL NA NA 0  0 3-4 0 0 0 
 Size lens spec. 12.5 0 1 NA 0 0 0 0 0 
9 Habitual spec 12.5 5 2  5 4 0 0 0 
 CL NA NA 2  5 5 0 0 0 
 Size lens spec. 12.5 3* 2* 4 BO 1 4 0 0 0 
10 Habitual spec 160 3 4  5 3 0 0 0 
 CL NA NA 1  2 1 0 0 0 
 Size lens spec. 160 0 1* 2 BI 2 0 0 0 0 
Habitual spec.: Habitual spectacle, CL: contact lens, Size lens spec.:size lens spectacle, AIS : aniseikonia inspector software, NA: not available, BI: base in, BO:base out 
* aniseikonia improve to 0% when neutralize with prism with size lens spectacle 
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